引用本文: | 邬麟, 卢红莲. Tepotinib治疗MET 14外显子跳读突变非小细胞肺癌患者的疗效与安全性[J]. 循证医学, 2020, 20(5): 268-271. DOI: 10.12019/j.issn.1671-5144.2020.05.004 |
Citation: | WU Lin, LU Hong-lian. Efficacy and Safety of Tepotinib in Non-Small-Cell Lung Cancer With MET Exon 14 Skipping Mutations[J]. Journal of Evidence-Based Medicine, 2020, 20(5): 268-271. DOI: 10.12019/j.issn.1671-5144.2020.05.004 |